Table 5. Regression analyses of ORR in the XELOX group.
ORR | Coef. | Std. Err. | t | P | 95% CI |
---|---|---|---|---|---|
Study type | –0.2529 | 0.112954 | –2.24 | 0.052 | –0.50842 to 0.002623 |
Gender | 0.422701 | 0.484584 | 0.87 | 0.406 | –0.673505 to 1.518906 |
_cons | 0.262381 | 0.294841 | 0.89 | 0.397 | –0.404595 to 0.929357 |
ORR, objective response rate; XELOX, oxaliplatin combined with capecitabine; Coef., coefficient; Std. Err., standard error; CI, confidence interval.